Aether Industries Limited (AETHER)
🎯 Key Takeaways
- Aether Industries Limited is in a high-growth phase, transitioning from a startup chemical manufacturer to a scaled player in specialty chemicals with expanding global footprint. Management is actively investing in capacity expansion and R&D to capture demand in CEM and CRAMS segments, supported by strong top-line growth and improving margins.
- Revenue grew 0% QoQ to ₹305 in Q4FY26.
- ⚠️ 1) Execution risk around new site ramp-ups (Site 3++ and Site 5) could delay revenue contribution and pressure near-term margins. 2) Fire-related inci
📖 The Story
Aether Industries Limited is in a high-growth phase, transitioning from a startup chemical manufacturer to a scaled player in specialty chemicals with expanding global footprint. Management is actively investing in capacity expansion and R&D to capture demand in CEM and CRAMS segments, supported by strong top-line growth and improving margins. The company has demonstrated resilience through operational disruptions, including fire-related losses, while maintaining financial compliance and audit integrity.
📰 What's Happening
In FY26, Aether reported consolidated revenue of ₹11,601 M, up 38% YoY, driven by growth in CEM and CRAMS businesses, with EBITDA and PAT rising 53% and 39% respectively. Management highlighted the ramp-up of commercial production at Site 3++ in Q1 FY27 and Phase 1 of Site 5 slated for completion in June 2026. The company also allotted shares under its ESOP 2021 twice in May and June 2026, increasing total shares outstanding to over 13.27 crore. Additionally, the board approved audited FY2026 results, confirming profitability despite fire-related asset losses of ₹369.68 million, partially offset by insurance recoveries.
Source: Stock Announcements
📊 Quarterly Results (₹ Cr)
| Metric | Q2FY25 | Q3FY25 | Q4FY25 | Q1FY26 | Q2FY26 | Q3FY26 | Q4FY26 | Q4FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 199 | 220 | 240 | 256 | 275 | 317 | 305 | 305 |
| Operating Profit | 61 | 76 | 82 | 81 | 94 | 108 | 93 | 93 |
| OPM % | 27.0% | 29.5% | 33.2% | 31.5% | 32.0% | 34.9% | 27.1% | 27.1% |
| Net Profit | 35 | 43 | 50 | 47 | 54 | 64 | 54 | 54 |
| EPS | ₹2.63 | ₹3.27 | ₹3.79 | ₹3.55 | ₹4.07 | ₹4.86 | ₹4.07 | ₹4.07 |
Revenue has grown consistently from ₹199 crore in Q2FY25 to ₹305 crore in Q4FY26, reflecting successful scaling of operations and new site commissioning. Operating margins remain robust at 27-35%, indicating efficient execution of expansion plans. However, a sequential decline in revenue and margins from Q3FY26 to Q4FY26 suggests potential macro or demand-side headwinds, which management may address through capacity additions and R&D-led product diversification.
🔮 Management Outlook & What's Next
Management expressed confidence in growth momentum, citing the ramp-up of Site 3++ and commercial readiness of Site 5 by June 2026 as key catalysts. They emphasized ongoing investments in R&D and production infrastructure to sustain competitive advantage in high-value chemical segments. No formal financial guidance was provided in the filings, but operational milestones were presented as indicators of future performance.
Extracted from official company announcements. Not StockFin.ai's opinion.
🏦 Balance Sheet (₹ Cr)
| Item | 2025-2026 | 2025-2026 | 2025-2026 | 2025-2026 | 2025-2026 |
|---|---|---|---|---|---|
| Equity Capital | 133 | 133 | 133 | 133 | 133 |
| Reserves | — | 2,196 | — | 2,323 | 2,323 |
| Borrowings | — | 213 | — | 442 | 442 |
| Total Liabilities | — | 521 | — | 746 | 746 |
| Fixed Assets | — | 971 | — | 1,236 | 1,236 |
| Investments | — | 0 | — | 0 | 0 |
| Total Assets | — | 2,849 | — | 3,201 | 3,201 |
The company maintains a strong balance sheet with equity of ₹133 crore, reserves of ₹2,323 crore, and borrowings of ₹442 crore, supporting its capital-intensive expansion strategy. Total assets of ₹3,201 crore reflect investments in property, plant, and subsidiary operations, indicating active reinvestment. The capital structure remains conservative with low debt-to-equity of 0.18, suggesting prudent financial management amid growth.
⚖️ Peer Comparison — Chemicals & Petrochemicals
| Company | MCap (₹ Cr) | P/E | ROCE | ROE | D/E |
|---|---|---|---|---|---|
| Solar Industries India Limited | 1.57 L Cr | 132.3 | — | — | — |
| Pidilite Industries Limited | 1.49 L Cr | 75.7 | — | — | — |
| SRF Limited | 79,723 | 69.5 | — | — | — |
| Linde India Limited | 62,701 | 141.9 | — | — | — |
| Gujarat Fluorochemicals Limited | 40,793 | 89.6 | — | — | — |
| Navin Fluorine International Limited | 35,894 | 131.5 | — | — | — |
| Himadri Speciality Chemical Limited | 30,071 | 56.6 | — | — | — |
| Deepak Nitrite Limited | 24,911 | 33.3 | — | — | — |
| Atul Limited | 20,904 | 48.8 | — | — | — |
| Tata Chemicals Limited | 19,079 | -47.1 | — | — | — |
🔗 Peer Stock Analyses
⚠️ Risk Factors
1) Execution risk around new site ramp-ups (Site 3++ and Site 5) could delay revenue contribution and pressure near-term margins. 2) Fire-related incidents and insurance recoveries introduce volatility in operational and financial outcomes. 3) GST demand of ₹4.26 crore over IPO expense disallowance, while non-material, highlights tax uncertainty in complex regulatory environments. 4) High valuation (P/E 65.1) may limit investor tolerance for execution missteps.
📋 Recent Filings
-
🔴 Corporate Action 15 June 2026Aether Industries approved the allotment of 3,677 equity shares under its Employee Stock Option Scheme 2021, exercising options at Rs. 885 per share. ...
-
Announcement 6 June 2026Aether Industries announced it received the final insurance claim settlement of approximately ₹100 crores related to the November 2023 fire accident, ...
-
🔴 Corporate Action 19 May 2026Aether Industries approved the allotment of 29,075 equity shares under its Employee Stock Option Scheme 2021 at an exercise price of Rs. 885 per share...
-
Announcement 19 May 2026Aether Industries Limited announced its upcoming investor meetings schedule in Mumbai, including one-on-one sessions with Ambit India on May 25 and pa...
-
🔴 Financial Results 15 May 2026Aether Industries announced the audio recording of its Q4 FY2026 earnings conference call, made available on its website on May 15, 2026, per SEBI dis...
-
🟡 Board Meeting 15 May 2026Aether Industries Limited approved its audited FY2026 financial results on May 15, 2026, confirming a consolidated revenue of Rs 316,339 million and p...
-
🔴 Financial Results 15 May 2026Aether Industries reported consolidated revenue of ₹11,601 M for FY26, up 38% YoY, driven by strong performance in CEM and CRAMS businesses. EBITDA ro...
-
🔴 offer document 24 April 2026Aether Industries received a GST demand of Rs. 4.26 crores from Surat's Additional Commissioner for FY 2020-21 and 2021-22, related to IPO expenses, b...
-
🔴 Insider Trading 9 April 2026Ashwin Jayantilal Desai, Managing Director and Promoter of Aether Industries Limited, disclosed under SEBI (SAST) Regulation 31(4) that no share encum...
-
🔴 Corporate Action 27 March 2026Aether Industries Limited allotted **5,454 equity shares** on March 27, 2026, under its Employee Stock Option Scheme 2021 at an exercise price of **₹8...
🧠 Analyst's Read
Aether Industries is executing a capital-intensive growth strategy with strong top-line momentum, but near-term volatility is likely due to expansion phases and regulatory exposures. Investors should monitor the successful commissioning of new sites and management's ability to sustain margins amid scaling challenges.
Based on filing content and financial data. Not a recommendation.
Data sourced from stock announcements. Analysis generated by StockFin.ai.
For informational purposes only — not investment advice. Updated 2026-06-16.